Douglas Bettinger Sells 40,080 Shares of Lam Research (NASDAQ:LRCX) Stock

Lam Research Corporation (NASDAQ:LRCX) CFO Douglas Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Lam Research Stock Down 2.9%

Lam Research stock opened at $143.24 on Wednesday. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $167.15. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The firm’s 50-day simple moving average is $142.35 and its 200 day simple moving average is $110.96. The stock has a market cap of $179.91 billion, a PE ratio of 31.55, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter last year, the firm earned $0.86 EPS. The company’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Research analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be given a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s payout ratio is currently 22.91%.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. IMG Wealth Management Inc. bought a new position in shares of Lam Research in the second quarter worth $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research during the 2nd quarter worth about $27,000. Triumph Capital Management bought a new position in Lam Research in the 3rd quarter worth about $27,000. Strategic Wealth Investment Group LLC purchased a new position in Lam Research during the 2nd quarter valued at about $29,000. Finally, Delos Wealth Advisors LLC bought a new stake in shares of Lam Research during the second quarter valued at about $30,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on LRCX. Mizuho raised their target price on Lam Research from $162.00 to $170.00 and gave the company an “outperform” rating in a research report on Thursday, October 23rd. TD Cowen raised their price objective on shares of Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Barclays set a $142.00 price objective on shares of Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. Stifel Nicolaus set a $160.00 target price on shares of Lam Research and gave the company a “buy” rating in a research report on Thursday, October 23rd. Finally, UBS Group set a $165.00 price target on shares of Lam Research and gave the stock a “buy” rating in a research note on Thursday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $149.04.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.